A Study to Evaluate Efficacy and Safety of TEZ/IVA in Subjects Aged 6 Through 11 Years With Cystic Fibrosis
Clinical trial NCT03559062 · COMPLETED
Trial details
- NCT number
- NCT03559062
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-17
- Primary completion
- 2018-12-21
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.